Merck to repurchase $5B in common stock
1 day ago
Merck & Co Inc. said it will repurchase $5 billion worth of its common stock under an accelerated share repurchase agreement with Goldman Sachs & Co.
Merck replacing R&D head with former company exec
76 days ago
The world's third-biggest drugmaker by revenue says Dr. Roger Perlmutter, a former research executive at Merck and Amgen Inc., will begin running Merck Research Laboratories on April 15.
Merck settles investor suits on cholesterol drugs
98 days ago
Merck & Co. has agreed to pay $688 million to settle two lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop...
Analyst downgrades Merck on concerns over 2 drugs
107 days ago
Shares of drugmaker Merck & Co. declined after an analyst downgraded them from "Buy" to "Sell."
Futures moving higher on strong jobs numbers
111 days ago
The drugmaker Merck & Co. saw generic competition cut into earnings.
Generic competition, charges cut Merck Q4 profit
111 days ago
Merck & Co. says its fourth-quarter profit fell 7 percent as generic competition slashed sales of its blockbuster allergy drug Singulair and the drugmaker took sizeable restructuring and...
